v3.26.1
Cover
Feb. 20, 2026
Cover [Abstract]  
Document Type 8-K/A
Amendment Flag true
Amendment Description Explanatory Note: On February 20, 2026, Insight Molecular Diagnostics Inc. (“we,” “us,” “our,” the “Company” or “iMDx”) filed a Current Report on Form 8-K under Item 1.01 announcing that it had entered into a Specimen Collection Agreement with Quest Diagnostics Incorporated (“Quest Diagnostics”). This information was inadvertently filed under Item 1.01. This report corrects and amends that filing by moving the disclosure regarding the agreement with Quest Diagnostics under Item 8.01.
Document Period End Date Feb. 20, 2026
Entity File Number 1-37648
Entity Registrant Name Insight Molecular Diagnostics Inc.
Entity Central Index Key 0001642380
Entity Tax Identification Number 27-1041563
Entity Incorporation, State or Country Code CA
Entity Address, Address Line One 2 International Plaza Dr.
Entity Address, Address Line Two Suite 510
Entity Address, City or Town Nashville
Entity Address, State or Province TN
Entity Address, Postal Zip Code 37217
City Area Code (615)
Local Phone Number 255-8880
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock, no par value
Trading Symbol IMDX
Security Exchange Name NASDAQ
Entity Emerging Growth Company false